Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 1
2008 2
2010 1
2012 2
2013 3
2015 1
2016 2
2017 1
2018 1
2019 5
2020 3
2021 4
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Potency assays and biomarkers for cell-based advanced therapy medicinal products.
Capelli C, Cuofano C, Pavoni C, Frigerio S, Lisini D, Nava S, Quaroni M, Colombo V, Galli F, Bezukladova S, Panina-Bordignon P, Gaipa G, Comoli P, Cossu G, Martino G, Biondi A, Introna M, Golay J. Capelli C, et al. Among authors: nava s. Front Immunol. 2023 Jun 9;14:1186224. doi: 10.3389/fimmu.2023.1186224. eCollection 2023. Front Immunol. 2023. PMID: 37359560 Free PMC article. Review.
Clinical Management of Moyamoya Patients.
Canavero I, Vetrano IG, Zedde M, Pascarella R, Gatti L, Acerbi F, Nava S, Ferroli P, Parati EA, Bersano A. Canavero I, et al. Among authors: nava s. J Clin Med. 2021 Aug 17;10(16):3628. doi: 10.3390/jcm10163628. J Clin Med. 2021. PMID: 34441923 Free PMC article. Review.
Vasculogenic and Angiogenic Pathways in Moyamoya Disease.
Bedini G, Blecharz KG, Nava S, Vajkoczy P, Alessandri G, Ranieri M, Acerbi F, Ferroli P, Riva D, Esposito S, Pantaleoni C, Nardocci N, Zibordi F, Ciceri E, Parati EA, Bersano A. Bedini G, et al. Among authors: nava s. Curr Med Chem. 2016;23(4):315-45. doi: 10.2174/092986732304160204181543. Curr Med Chem. 2016. PMID: 26861126 Review.
Research Progresses in Understanding the Pathophysiology of Moyamoya Disease.
Bersano A, Guey S, Bedini G, Nava S, Hervé D, Vajkoczy P, Tatlisumak T, Sareela M, van der Zwan A, Klijn CJ, Braun KP, Kronenburg A, Acerbi F, Brown MM, Calviere L, Cordonnier C, Henon H, Thines L, Khan N, Czabanka M, Kraemer M, Simister R, Prontera P, Tournier-Lasserve E, Parati E; European Moyamoya Disease Initiative. Bersano A, et al. Among authors: nava s. Cerebrovasc Dis. 2016;41(3-4):105-18. doi: 10.1159/000442298. Epub 2016 Jan 12. Cerebrovasc Dis. 2016. PMID: 26756907 Free article. Review.
Plasma Lipid Profiling Contributes to Untangle the Complexity of Moyamoya Arteriopathy.
Dei Cas M, Carrozzini T, Pollaci G, Potenza A, Nava S, Canavero I, Tinelli F, Gorla G, Vetrano IG, Acerbi F, Ferroli P, Ciceri EF, Esposito S, Saletti V, Ciusani E, Zulueta A, Paroni R, Parati EA, Ghidoni R, Bersano A, Gatti L. Dei Cas M, et al. Among authors: nava s. Int J Mol Sci. 2021 Dec 14;22(24):13410. doi: 10.3390/ijms222413410. Int J Mol Sci. 2021. PMID: 34948203 Free PMC article.
A comprehensive report of long-term stability data for a range ATMPs: A need to develop guidelines for safe and harmonized stability studies.
Capelli C, Frigerio S, Lisini D, Nava S, Gaipa G, Belotti D, Cabiati B, Budelli S, Lazzari L, Bagnarino J, Tanzi M, Comoli P, Perico N, Introna M, Golay J. Capelli C, et al. Among authors: nava s. Cytotherapy. 2022 May;24(5):544-556. doi: 10.1016/j.jcyt.2021.12.004. Epub 2022 Feb 15. Cytotherapy. 2022. PMID: 35177338 Free article.
31 results